Aptevo Therapeutics Inc (NASDAQ:APVO) does about 6.39M shares in volume on a normal day but saw 749714 shares change hands in the recent trading day. The company now has a market cap of 1.44M USD. Its current market price is $0.15, marking a decrease of -7.23% compared to the previous close of $0.16. The 52 week high reached by this stock is $21.56 whilst the lowest price level in 52 weeks is $0.14.
Aptevo Therapeutics Inc (APVO) has a 20-day trading average at $0.2086 and the current price is -99.29% off the 52-week high compared with 8.37% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3139 and its 200-day simple moving average is $2.6382. If we look at the stock’s price movements over the week, volatility stands at 8.46%, which increases to 14.41% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 24.95 to suggest the stock is oversold.
The consensus objective for the share price is $8.00, suggesting that the stock has a potential upside of 98.12% over the period.
The current price level is -26.76%, -51.32%, and -94.21% away from its SMA20, SMA50, and SMA200 respectively, with the APVO price moving above the 50-day SMA on current market day. Aptevo Therapeutics Inc (APVO) stock is down -9.10% over the week and -56.21% over the past month. Its price is -98.08% year-to-date and -98.95% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of -22 above consensus estimates by 11. The company’s next earnings report forecasts estimating quarterly EPS at -3.35 and -17.23 for whole year.
To reach the target analysts have set, the stock logically needs to grow 98.12 percent from here.
The company has a return on investment of -263.01% and return on equity of -243.74%. The beta has a value of 5.14. Price to book ratio is 0.14.
